Latest ArticlesIn this report, 4-nitrophenylacetic acid(5) reacted with acetic anhydride to give 1-(4-nitrophenyl)-propan-2-one(6). Condensation of 6 with ethyl cyanoacetate followed by cyclization with sulfur afforded ethyl 2-amino-4-methyl-5-(4-nitrophenyl)thiophene-3-carboxylate(7), which was acylated with butyl chloroformate to afford ethyl 2-[(butoxycarbonyl)amino]-4-methyl-5-(4-nitrophenyl)thiophene-3-carboxylate(8). Then 8 was substituted with 2,6-difluorobenzyl chloride and the resulting product ethyl 2-[(butoxycarbonyl)(2,6-difluorobenzyl)amino]-4-methyl-5-(4-nitrophenyl)thiophene-3-carboxylate(9) was reacted with N-bromosuccinimide and dimethylamine to generate ethyl 2-[(butoxycarbonyl)(2,6-difluorobenzyl)amino]-4-[(dimethylamino)methyl]-5-(4-nitrophenyl)thiophene-3-carboxylate(11). And then 2-[(butoxycarbonyl)(2,6-difluorobenzyl)amino]-4-[(dimethylamino)methyl]-5-(4-nitrophenyl)thiophene-3-carboxylic acid(12) was obtained after hydrolysis of 11 with potassium hydroxide. Next, 12 was subjected to condensation with 3-amino-6-methoxypyridazine and cyclization with sodium methoxide to result in 1-(2,6-difluorobenzyl)-5-[(dimethylamino)methyl]-3-(6-methoxypyridazin-3-yl)-6-(4-nitrophenyl)thieno[2,3-d]-pyrimidine-2,4(1H,3H)-dione(14). Then 14 reacted with hydrogen under catalysis of Pd/C to afford 6-(4-aminophenyl)-1-(2,6-difluorobenzyl)-5-[(dimethylamino)methyl]-3-(6-methoxypyridazin-3-yl)thieno[2,3-d]pyrimidine-2,4(1H,3H)-dione(15). Finally, Substitution of 15 with phenyl chloroformate and methoxamine hydrochloride reduction to prepare relugolix(1) with an overall yield of 22.9% (based on 5).
This study improved the synthesis process of perampanel(1). 5-Bromo-2-methoxypyridine(3) was prepared by bromination of 2-methoxypyridine(2), and then Kumada coupling of 3 with 2-bromopyridine was carried out to prepare 6'-methoxy-2,3'-bipyridine(4), followed by the hydrolysis with hydrochloric acid to obtain [2,3'-bipyridyl]-6'(1'H)-one(6), the latter underwent the Chan-Evans-Lam coupling reaction with phenylboronic anhydride to give 1'-phenyl-[2,3'-bipyridyl]-6'(1'H)-one(7), which was then brominated with NBS to give 5'-bromo-1'-phenyl-[2',3-dipyridyl]-6(1'H)one(8), finally the Suzuki coupling of 8 with 2-(1,3,2-dioxaborexan-2-yl) benzonitrile(9) in palladium acetate/occurred under the catalysis of triphenylphosphine to give 1 with a total yield of 34% (based on 2).
5-Bromo-2-chloro-4-(cyclopentamino) pyrimidine(3) was prepared by substitution of 5-bromo-2,4-dichloropyrimidine(2). Subsequently, 3 was used to synthesize 3-[2-chloro-4-(cyclopentylamino)pyrimidin-5-yl]prop-2-yn-1-ol(4) through Sonogashira coupling reaction. Next, 4 was subjected to cyclization in the presence of tetrabutylammonium fluoride to produce (2-chloro-7-cyclopentyl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)methanol(5). The oxidation of 5 by 2,2,6,6-tetramethylpiperidine 1-oxyl(TEMPO)/NaClO2 in flow reactor yielded 2-chloro-7-cyclopentyl-7H-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid(6). At last, the key intermediate of ribociclib, 2-chloro-7-cyclopentyl-N, N-dimethyl-7H-pyrrolo[2,3-d]pyrimidine-6-carboxamide(1) was synthesized by acylation from compound 6 in 51% of overall yield(based on 2) and with 99.2% of HPLC purity. In this paper, DL-α-tocopherol methoxypolyethylene glycol succinate (TPGS-750-M) aqueous solution was used as the reaction solvent to improve the yield of Sonogashira coupling reaction greatly by micellar chemistry. In addition, continuous flow chemistry was adopted to avoid the risks of oxidation reaction and simplify the operations.
This study obtained variable domain of light amyloid AL-09 and Vλ6wil from inclusion bodies through constructing Escherichia coli expression vectors and optimizing the induction conditions. Then the aggregation activity of AL-09 and Vλ6wil in vitro was detected by thioflavin T(ThT) assay, and the cytotoxicity to AC16 cells was preliminarily identified by MTT assay. The results showed that the optimal isopropyl-beta-D-thiogalactopyranoside concentrations for AL-09 and Vλ6wil expression were respectively 0.2 and 0.4 mmol/L, and the optimal expression time was 3 h. Under the optimal condition, the yields could reach around 10 mg/L. Both AL-09 and Vλ6wil were proved to have the capacity to form fibrils in vitro and showed significant cytotoxicity to AC16 cells. In conclusion, we established an inclusion body expression system for light chain amyloid, which provided a specific research basis for the further study of amyloidosis.
In the preparation of recombinant polypeptide and protein drugs, the bovine enterokinase light chain is one of the most widely used tool enzymes. However, its low expression level leads to high production costs. This study used high-density fermentation technology to obtain the extracellular secretion and expression of the bovine enterokinase light chain based on a high-expressing recombinant bacteria screen. The high-density fermentation process of the engineered bacteria was optimized, and the expression yield of the target protein was increased to (478.47±1.70)mg/L. The target protein was separated and extracted from the fermentation liquid by centrifugation, microfiltration, ultrafiltration and ion-exchange chromatography, and the its purity reached (97.94±0.42)%. Finally, the enzymatic properties of the recombinant bovine enterokinase light chain were characterized. This study has opened up the small-scale preparation process route of recombinant bovine enterokinase light chain, paving the way for its application as a tool enzyme in peptide drug production.
Dispersion process may affect the stability of budesonide(BUD) suspension for inhalation. In this study, the effects of dispersion parameters on stability of BUD suspension were evaluated by multiple light scattering method among formulations with different dispersion time(lengths 30, 60, 90, 120 min). For dispersion 60 min group, that values of stability index from top & middle suspension system, average level of total system were smaller comparing with other groups. This suggested that the 60 min dispersion group with better stability attribute. To further evaluate stability in storage, samples from different dispersion time lengths group were placed in different conditions, such as high temperature[(60±2)℃] for 0, 5 and 10 days and accelerated condition[(40±2)℃ and relative humidity of (75±5)%] for 0, 10, 15 and 30 days. In the end of storage period, the particle size distribution(PSD) of the BUD particle in suspension was detected by laser particle sizer, and the aerodynamic particle size distribution of the suspension was detected by a new generation impactor. The results showed that there were no significant differences in the PSD and aerodynamic particle size distribution of the suspension obtained at different dispersion time lengths. For accelerated condition groups, the BUD PSD in all different dispersion groups increased with the increase of storage period. Among this, for 60 min dispersion group, the testing value of volume median diameter(VMD) increased, comparing with those of groups with significant differences(P<0.05). These results showed characterization of high thermodynamic stability in 60 min dispersion suspension formulation.
This paper aimed to study the effects of excipients and preparation process on the compressibility of Weisu effervescent tablets. The representative excipients(effervescent disintegrating agent, magnesium stearate and lactose) commonly used in effervescent tablets and Weisu extract were employed in this research, and the tensile strength, parameters in the compression molding process and yield pressure were taken as the evaluation indexes. The effects of preparation process, direct compression and dry granulation tableting techniques, on the compressibility of Weisu effervescent tablets were investigated combined with physical characteristics. The results showed that the physical properties and compaction behavior of the powders were significantly affected by the effervescent disintegrating agent and the preparation process. The Heckel equations showed that the Weisu extract powder mainly exhibited plastic deformation during the compression process. Compared with direct compression, the physical properties of the granules prepared by dry granulation showed significant differences, such as lower compatibility and significantly improved flowability. Compared with direct compaction, dry granulation tableting was more suitable for the preparation of Weisu effervescent tablets when the actual production factors are taken into account.
The container closure integrity for prefilled syringes under vaporized hydrogen peroxide(VHP) sterilization in isolators was investigated and its potential risks were discussed. The bacterial solution of Staphylococcus aureus was added into the prefilled syringe, then the syringe was placed in the isolator according to the method of sterility inspection. The surface sterilization was carried out by the VHP sterilization method which had been verified. The ultraviolet(UV) sterilization was used as the control experiment, and the bacterial counts were performed on the contents of prefilled syringes with two sterilization methods. The results showed that under the VHP sterilization, the sealing integrity of the prefilled syringe containers was damaged, and the mortality rate of Staphylococcus aureus in the contents was 90%. It was showed that when the prefilled syringes were subjected to the sterility inspection of VHP sterilization method, VHP would enter the interior through the packaging system, killing the microorganisms might exist in the tested sample.
This study established a mass extraction method to test the package integrity of the injection vials. On the basis of rationally setting parameters and preparing negative and positive samples, the test time for vacuuming and detection of micro-leakage was optimized, and the method validation was carried out. In this paper, the results of the mass extraction method to test the package integrity of the injection vials showed that the sample pore size had a good linear relationship with the flow rate, and the detection and the quantification limits were 0.2 and 0.5 μm, respectively. The mass extraction method for the package integrity testing of the injection vials had high sensitivity, good accuracy, daytime stability, and durability. The method established in this study can effectively test the integrity of the vial packaging system and provide an experimental reference for establishing the test standard for the integrity of the vial packaging system.
An HPLC method was established for the determination of the related substances specified in US pharmacopoeia 40 as impurities A to F in rabeprazole sodium(1) enteric-coated tablets. The Thermo Hypersil BDS C18 column(4.6 mm×250 mm, 5 μm) was used, and the analysis was carried out in the gradient elution mode with acetonitrile∶4.35 g/L dipotassium hydrogen phosphate solution(adjusted to pH 7.0 with phosphoric acid)(5∶95) as mobile phase A, methanol as mobile phase B, and acetonitrile as mobile phase C. The detection wavelength was 280 nm, the column temperature was 45 ℃, and the injection volume was 5 µl. The results showed that it was linear for 1 in the range of 0.3 - 102.5 μg/ml, and the detection limit was 0.3 ng. The peaks of 1 and each impurity could be completely separated, and the excipients did not interfere with the determination. Compared with the method in Chinese pharmacopoeia 2020, the established method not only could accurately determine the common impurity(impurity A)found in twenty-one batches of 1 enteric-coated tablets, but also control other three known impurities(impurity B, C, F), which provided a reference for the improvement of the specification on active pharmaceutical ingredient and the formulation of 1.